Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY 4.0PeerJ

Optimizing exercise prescriptions for older adults with mild cognitive impairment: a dose–response network meta-analysis of modality–dose combinations on executive function

  1. 1School of Football, Wuhan Sports University, Wuhan, Hubei, China
  2. 2The College of Physical Education, Minnan Normal University, Zhangzhou, Fujian, China
  3. 3Nanfang College Guangzhou, Guangzhou, Guangdong, China

Abstract

Objective: To use a Bayesian network dose–response meta-analysis to determine how overall exercise dose and different exercise modalities influence the three core domains of executive function-working memory, cognitive flexibility, and inhibitory control-in older adults with mild cognitive impairment.

Methods: PubMed, Embase, Web of Science, and the Cochrane Library were searched through 10 November 2025 for randomized controlled trials. Two reviewers independently screened eligible studies. Studies were included if they enrolled adults aged ≥60 years with mild cognitive impairment, evaluated repeated exercise programmes, included usual care, low-intensity activity, or another exercise modality as a comparator, and reported at least one outcome of working memory, cognitive flexibility, or inhibitory control. Studies were excluded if participants had dementia or other neurological conditions affecting cognition, if only acute single-bout exercise was examined, if the study was non-randomized or non-peer-reviewed, if essential outcome data were unavailable, or if the Physiotherapy Evidence Database score was <4. Exercise dose was standardized as metabolic equivalents (METs)⋅min/week, and Bayesian model-based network meta-analysis was used to estimate non-linear overall and modality-specific dose–response relationships.

Results: Thirty-eight studies met the eligibility criteria. Across all three executive-function dimensions, the overall dose–response curves exhibited a characteristic non-linear improvement pattern. Moderate exercise doses (approximately 300–1,000 METs⋅min/week) were associated with the most reliable gains, whereas higher-dose ranges showed plateaus or modest declines. Effective dose windows varied by modality and cognitive dimension: Exercise Joint Cognitive Training yielded the most consistent improvements in working memory, while Comprehensive Physical Training and Walking Aerobic Exercise demonstrated more stable effects on cognitive flexibility and inhibitory control. Sensitivity analyses supported the stability of the models. The certainty of evidence ranged from low to moderate, and publication bias was minimal.

Conclusion: Exercise yields a non-linear dose–response relationship with executive function in older adults with mild cognitive impairment, with moderate doses producing the most robust improvements. Distinct optimal dose windows exist across cognitive dimensions and exercise modalities, offering a basis for precision exercise–cognition prescriptions. These findings support prioritizing dose-informed intervention strategies in ageing and cognitive-decline management and highlight the need for future trials adopting multi-dose gradient designs to validate optimal dose ranges.

Related

  1. Executive dysfunction in COPD: prevalence and clinical correlates of cognitive impairment : A cross-sectional case–control study
    Hüsniye Aylin Dikbaş, Ruhsel Cörüt, Ali Muhtaroğlu
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Effects of motor-cognitive dual-task training on executive function in older adults with mild cognitive impairment: A multilevel dose-response meta-analysis.
    Xinyuan Yin, Zhikai Qin, Shengyu Dai +5
    Journal of exercise science and fitnessPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMC
  3. Integrated Emotional Schema Therapy and the Unified Protocol for Executive Functioning Difficulties and Cognitive Emotion Regulation in Generalized Anxiety Disorder
    Mahsa Khajooei, Marzie Hashemi
    International Journal of Body, Mind and CulturePeer-reviewedCC BY-NCFull textGeneral medicineDOAJ
  4. Trimester-Specific Associations Between Maternal Fatty Acid Ratios and Cognitive and Executive Functioning in 4-Year-Old Children
    Xiruo Kou, Josefa Canals, Victoria Arija
    NutrientsPeer-reviewedCC BY 4.0NutritionCrossref
  5. Updating deficits in subjective cognitive decline: A differential pattern of executive dysfunction across clinical stages.
    Yuetan Wang, Wenni Zhan, Zhuoyan Wu +3
    International journal of clinical and health psychology : IJCHPPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMC
BibTeX
@article{song2026optimizing,
  title = {{Optimizing exercise prescriptions for older adults with mild cognitive impairment: a dose–response network meta-analysis of modality–dose combinations on executive function}},
  author = {Mingliang Song and Qiang Xiong and Xiaojin Qin},
  journal = {PeerJ},
  year = {2026},
  month = oct,
  doi = {10.7717/peerj.21805},
  url = {https://peerj.com/articles/21805},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Optimizing exercise prescriptions for older adults with mild cognitive impairment: a dose–response network meta-analysis of modality–dose combinations on executive function
AU  - Mingliang Song
AU  - Qiang Xiong
AU  - Xiaojin Qin
PY  - 2026
DA  - 2026/10/20
JO  - PeerJ
DO  - 10.7717/peerj.21805
UR  - https://peerj.com/articles/21805
AB  - Objective: To use a Bayesian network dose–response meta-analysis to determine how overall exercise dose and different exercise modalities influence the three core domains of executive function-working memory, cognitive flexibility, and inhibitory control-in older adults with mild cognitive impairment.  Methods: PubMed, Embase, Web of Science, and the Cochrane Library were searched through 10 November 2025 for randomized controlled trials. Two reviewers independently screened eligible studies. Studies were included if they enrolled adults aged ≥60 years with mild cognitive impairment, evaluated repeated exercise programmes, included usual care, low-intensity activity, or another exercise modality as a comparator, and reported at least one outcome of working memory, cognitive flexibility, or inhibitory control. Studies were excluded if participants had dementia or other neurological conditions affecting cognition, if only acute single-bout exercise was examined, if the study was non-randomized or non-peer-reviewed, if essential outcome data were unavailable, or if the Physiotherapy Evidence Database score was <4. Exercise dose was standardized as metabolic equivalents (METs)⋅min/week, and Bayesian model-based network meta-analysis was used to estimate non-linear overall and modality-specific dose–response relationships.  Results: Thirty-eight studies met the eligibility criteria. Across all three executive-function dimensions, the overall dose–response curves exhibited a characteristic non-linear improvement pattern. Moderate exercise doses (approximately 300–1,000 METs⋅min/week) were associated with the most reliable gains, whereas higher-dose ranges showed plateaus or modest declines. Effective dose windows varied by modality and cognitive dimension: Exercise Joint Cognitive Training yielded the most consistent improvements in working memory, while Comprehensive Physical Training and Walking Aerobic Exercise demonstrated more stable effects on cognitive flexibility and inhibitory control. Sensitivity analyses supported the stability of the models. The certainty of evidence ranged from low to moderate, and publication bias was minimal.  Conclusion: Exercise yields a non-linear dose–response relationship with executive function in older adults with mild cognitive impairment, with moderate doses producing the most robust improvements. Distinct optimal dose windows exist across cognitive dimensions and exercise modalities, offering a basis for precision exercise–cognition prescriptions. These findings support prioritizing dose-informed intervention strategies in ageing and cognitive-decline management and highlight the need for future trials adopting multi-dose gradient designs to validate optimal dose ranges.
SN  - 2167-8359
ER  -